Pantoprazole Teva Sante (Pantoprazole Sodium Sesquihydrate)

Pantoprazole Sodium Sesquihydrate, the active ingredient in Pantoprazole Teva Sante, is a proton pump inhibitor presented as a tablet for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults. GNH USA supplies Pantoprazole Teva Sante as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Pantoprazole Teva Sante as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole Teva Sante is a proton pump inhibitor that addresses acid‑related gastrointestinal disorders.

- Gastro‑oesophageal reflux disease (GERD): helps reduce the frequency and severity of heartburn and regurgitation. - Erosive esophagitis: promotes the healing of erosive lesions in the esophagus. - Peptic ulcer disease: supports ulcer healing and helps prevent recurrence. - Zollinger‑Ellison syndrome: lowers excess gastric acid production associated with the condition. - Helicobacter pylori eradication regimens: used as part of combination therapy to improve ulcer healing rates.

Pantoprazole may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: excess intestinal gas. - Constipation: infrequent bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Acute interstitial nephritis: kidney inflammation with reduced urine output. - Severe hypersensitivity: rash, angio‑edema, or anaphylaxis. - Osteoporosis‑related fractures: increased risk with long‑term use. - Low magnesium (hypomagnesemia): muscle cramps, tremor, or cardiac arrhythmia. - Vitamin B12 deficiency: anemia or neurological symptoms with prolonged therapy.

Before prescribing Pantoprazole Teva Sante, consider patient‑specific factors and follow standard safety measures.

- Renal impairment: dose adjustment may be required in severe kidney disease. - Hepatic impairment: monitor liver function in patients with moderate to severe liver disease. - Long‑term use: assess need for continued therapy periodically to avoid bone density loss. - Pregnancy: use only if clearly needed after risk‑benefit evaluation. - Breastfeeding: weigh potential infant exposure against maternal benefit. - Drug interactions: review concomitant medications for known PK/PD interactions. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Pantoprazole can affect the absorption and metabolism of several co‑administered drugs. Monitoring and dose adjustments may be necessary.

Major Interactions (Avoid): - Atazanavir: reduced antiviral exposure; avoid concurrent use. - Nelfinavir: markedly decreased plasma concentrations.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR; monitor coagulation parameters. - Methotrexate: elevated serum levels; check renal function and drug levels. - Digoxin: modest increase in serum concentration; observe for toxicity. - Clopidogrel: diminished antiplatelet effect; consider alternative therapy. - Iron supplements: decreased iron absorption; separate dosing by at least 2 h.